• Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Othe... 4/25/2025
• Carterra Announced That It has Sold and Shipped Its First Carterra Ultra™ Biosensor ... 1/8/2025
• Carterra Expands Best-in-class Franchise with the Launch of the LSAXT High-throughput SPR ... 3/15/2023
• Carterra Expands Best-in-class Franchise with the Launch of the LSAXT High-throughput... 3/1/2023
• University of Manchester Adds Carterra’s LSA® Instrument for High-Throughput Antibody... 6/8/2022
• Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region 12/15/2021
• Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairm... 12/3/2020
• Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients 8/18/2020
• Carterra® Inc. Provides Antibody Screening and Characterization for the Coronavirus Im... 4/1/2020
• Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform 1/15/2020
• Carterra Developed Next Generation Antibody Screening Technology 9/6/2019
• Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion 8/15/2019